Navigation Links
Interferon does not slow or stop hepatitis C from worsening, study finds
Date:11/9/2007

Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who havent responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found.

Patients in the trial who were treated with interferon did experience a significant decrease in viral levels and liver inflammation, but the trial unequivocally demonstrated that treatment with long-term pegylated interferon also called peginterferon does not prevent the worsening of liver disease in patients whove failed prior treatments.

The results are this study are very clear long-term therapy with peginterferon for those with chronic hepatitis C is not effective in preventing progression of liver disease for patients who did not respond to an initial course of treatment, said Adrian Di Bisceglie, M.D., professor of internal medicine at Saint Louis University School of Medicine and chairman of the trials steering committee.

Furthermore, the relatively high rate of liver disease progression about 30 percent over nearly four years indicates the potential severity of chronic hepatitis C and emphasizes the importance of the ongoing search for new and more effective treatments, Di Bisceglie added.

Results of the study were reported by Di Bisceglie at the annual meeting of the American Association for the Study of Liver Disease in Boston this week.

Hepatitis C infects more than 100 million people worldwide and as many as 4 million people in the U.S. It ranks with alcohol abuse as the most common cause of chronic liver disease and leads to some 1,000 liver transplants in the U.S. each year.

The randomized, multi-site study involved 1,050 patients with chronic hepatitis C whod failed prior treatments to eradicate the infection. All had advanced liver fibrosis a gradual scarring of the liver that puts patients at risk for progress
'/>"/>

Contact: Donn Walker
dwalke18@slu.edu
314-977-8015
Saint Louis University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options
2. Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C
3. Stanford researchers find way to fight treacherous hepatitis B
4. Medical Services International Agrees to Retail the VScan Hepatitis B&C Test Kits in SE Asia
5. Hepatitis A Vaccine Best Bet to Treat Virus
6. Hepatitis C Testing Recommended for Anyone with a Tattoo
7. Is it pancreatitis in acute abdominal pain in acute viral hepatitis?
8. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
9. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
10. Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
11. HGS announces results of Phase 2B trial of Albuferon for chronic hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... its destruction inside a cell, a cancer-promoting growth ... the development of tumor-suppressing microRNAs (miRNAs) before it,s ... at Nature . , Under conditions of ... growth factor receptor (EGFR) gums up the cell,s ... at The University of Texas MD Anderson Cancer ...
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... -- Mayo Clinic researchers have used next generation genomic ... prostate cancer tumors have similar genetic origins, which may ... today in the journal Cancer Research . , ... using next generation sequencing in adjacent Gleason patterns in ... changes in pathology," says ,John Cheville, M.D., Mayo Clinic ...
(Date:5/23/2013)... "triple negative" carries a poor prognosis, with limited treatment ... cancer cells the way it,s supposed to. New research ... respond to chemotherapy, and identifies a mechanism to rectify ... Li, PhD, and his team at Western,s Schulich School ... Numb functions to promote the death of cancer cells ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a ... the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol , ... those who are considering filing lawsuits. , The ... severe liver damage, according to a 2009 report from ... “safety communication,” the FDA warned consumers against using more ...
Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... , TUCSON, Ariz. , ... PRSC ) today announced that Fletcher McCusker , Chairman and ... Company,s operations at the Jefferies 2010 Global Healthcare Services Conference on ... York .   , Providence,s presentation is scheduled for ...
... cheaper and more effective than existing products , WEDNESDAY, ... developed a new formula for a disinfectant that,s effective ... that cause mad cow disease. , The fast-acting disinfectant, ... it could, for instance, be used to rid surgical ...
... N.J. , Jan. 20 Which medical news stories are physicians reading to stay informed about key developments? MedPage ... Every Monday and will be available by visiting MedPageToday.com/Weekly-Top-Ten . , McNeil Expa n ... D r ug R ... z e n in ...
... ... the US marketplace in 2010. , ... Tucson, AZ (PRWEB) January 20, 2010 -- Sunquest, ... business solutions, is introducing its Integrated Clinical Environment™ (Sunquest ICE™) physician portal to ...
... ... solution. State Governments will save billions in medicaid costs, and prevent bankruptcies due to medical ... ... health care reform could bankrupt Medicaid. John Gwynne Prosser II observes California and ...
... Researchers at the University of Minnesota and Minneapolis VA ... brains of those exhibiting post-traumatic stress disorder (PTSD). ... in the study, which for the first time objectively ... magnetic fields in the brain. It,s something conventional brain ...
Cached Medicine News:Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 2Health News:Providence Service Corporation to Present at the Jefferies 2010 Global Healthcare Services Conference on Monday, January 25th 3Health News:MedPage Today(R) 'What Your Physicians Are Reading' 2Health News:MedPage Today(R) 'What Your Physicians Are Reading' 3Health News:Sunquest Introduces the Integrated Clinical Environment Physician Portal to US Marketplace 2Health News:Author John Gwynne Prosser II Offers "The Solution for Brain Injuries and Bankruptcies" With Free Educational Video Hosted by Google 2Health News:Researchers discover method to objectively identify PTSD 2
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
(Date:5/23/2013)... May 23, 2013  CAS Medical Systems, Inc. (NASDAQ: ... non-invasive patient monitoring, today announced that Thomas M. ... at the 2 nd Annual Marcum MicroCap Conference on ... New York City . The ... the Estate 10 room and will be available via a ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
... Calif., Sept. 23 Preclinical data of a ... blood pressure) was presented Tuesday, September 21st, at ... Washington, DC, by Christopher D. Owens, MD, MSc, ... Endovascular Surgery, University of California, San Francisco. The ...
... that a new market research report is available ... Surgical Devices: Technologies and Global Markets ... THIS REPORT CONTAINS A focus on ... devices and total disc replacement (TDR) are becoming the ...
Cached Medicine Technology:Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C. 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 3Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 4Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 5Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 6Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 7Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 8Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 9Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 10Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 11Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 12Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 13Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 14
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage system with self-contained ICP setting....
Medicine Products: